Get Live Data

Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Versarien Share Price
  4. Versarien Share Regulatory News
  5. Result of AGM

Pin to quick picksVersarien Regulatory News (VRS)

Versarien Information
  • This share is currently suspended. It was suspended at a price of 0.01
  • There is currently no data for VRS

Result of AGM

27 Sep 2016 13:38

RNS Number : 9735K
Versarien PLC
27 September 2016
 

 

27 September 2016

Versarien plc("Versarien" or the "Company")

Result of Annual General Meeting

 

Versarien Plc (AIM: VRS), the advanced materials engineering group, is pleased to confirm that at the Company's Annual General Meeting held today, all resolutions put to shareholders were duly passed.

 

For further information please contact:

 

Versarien plc

www.versarien.com

Neill Ricketts - Chief Executive Officer

+44 (0) 1594 888 622

Chris Leigh - Chief Financial Officer

 

 

 

WH Ireland (Nominated Adviser and Broker)

www.wh-ireland.co.uk

John Wakefield / Ed Allsopp

+44 (0) 117 945 3470

 

 

IFC Advisory (Financial PR and IR)

www.investor-focus.co.uk

Tim Metcalfe / Graham Herring / Heather Armstrong

+44 (0) 20 3053 8671

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGBDGDCLXDBGLR
12345678910
Date   Source Headline
9th Feb 20267:00 amRNSCancellation - Versarien Plc
6th Jan 20261:34 pmRNSAppointment of Administrators
19th Dec 20254:36 pmRNSUpdate on NOIA
19th Dec 20254:36 pmRNSUpdate on NOIA
15th Dec 20253:53 pmRNSUpdate on the Disposal of AAC Cyroma Limited
12th Dec 20257:00 amRNSUpdate on NOIA and Change of Registered Office
1st Dec 20257:30 amRNSSuspension - Versarien plc
1st Dec 20257:00 amRNSIntention to Appoint Administrators, Suspension
26th Nov 20257:00 amRNSUpdate - Proposed Disposal of the Company's Assets
31st Oct 20258:48 amRNSProposed Disposal of the Company’s Assets
29th Sep 20252:32 pmRNSCorporate Update
10th Sep 20251:00 pmRNSCorporate Update
29th Aug 20252:19 pmRNSCorporate Update
21st Aug 20257:00 amRNSStrategic Investment and Joint Venture Update
11th Aug 20257:00 amRNSCorporate Update
5th Aug 202511:03 amRNSHolding(s) in Company
29th Jul 20257:00 amRNSCorporate Update
22nd Jul 202510:55 amRNSSettlement of Legal Claims
4th Jul 20257:00 amRNS-RSouth American Polygrene™ Themoplastics Agreements
30th Jun 20253:03 pmRNSInterim Results
19th Jun 20252:34 pmRNSBuilding for Humanity – Contract Update
4th Jun 202511:49 amRNSHolding(s) in Company
2nd Jun 20252:03 pmRNSHolding(s) in Company
30th May 202510:19 amRNSHolding(s) in Company
30th May 20257:00 amRNSTotal Voting Rights
29th May 20253:29 pmRNSHolding(s) in Company
29th May 202510:20 amRNSHolding(s) in Company
27th May 202511:59 amRNSHolding(s) in Company
27th May 202511:02 amRNSHolding(s) in Company
23rd May 20259:38 amRNSHolding(s) in Company
22nd May 202511:56 amRNSHolding(s) in Company
21st May 202510:58 amRNSHolding(s) in Company
20th May 202511:11 amRNSHolding(s) in Company
14th May 20257:00 amRNSPlacing to raise £425,000
2nd May 202511:00 amRNSUpdate on Legal Claims
28th Apr 20251:04 pmRNSResult of AGM
27th Mar 20257:00 amRNSAudited Results for year ended 30 September 2024
24th Mar 202511:24 amRNSResult of General Meeting
10th Mar 20257:00 amRNS-RGraphinks™ supply agreement with Montana Química
5th Mar 20257:00 amRNSNotice of General Meeting
3rd Mar 20257:00 amRNSCompletion of Sale of Korean Assets
28th Feb 20257:00 amRNSTotal Voting Rights
27th Feb 20257:00 amRNSInnovate UK Loan Deed of Variation
10th Feb 20258:35 amRNSHolding(s) in Company
28th Jan 20252:36 pmRNSPlacing to raise £246k
30th Dec 202412:00 pmRNSUpdate on Sale of Korean Assets
13th Dec 20242:58 pmRNSHolding(s) in Company
13th Dec 202411:50 amRNSHolding(s) in Company
13th Dec 202410:11 amRNSHolding(s) in Company
13th Dec 20247:00 amRNS€804,000 Grant Award
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
OSEC
Octopus Aim 2
LSE
0.00%
MCM
MCM.L
LSE
0.00%
RTO
Rentokil Initial
LSE
-0.21%
TEEG
Telecom Egypt S
LSE
0.00%
GRN
GRN.L
LSE
0.00%
Trending
MAC
Marechale Cap.
LSE
0.00%
GGP
Greatland Resources
LSE
1.74%
GST
GSTechnologies
LSE
0.00%
ITM
Itm Power
LSE
-0.54%
IMM
Immupharma
LSE
0.54%